Metastasis Targeted Therapies in Renal Cell Cancer
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 1
Abstract
Metastatic renal cell cancer is a malignant disease and its treatment has been not been described clearly yet. These patients are generally symptomatic and resistant to current treatment modalities. Radiotherapy, chemotherapy, and hormonal therapy are not curative in many of these patients. A multimodal approach consisting of cytoreductive nephrectomy, systemic therapy (immunotherapy or targeted molecules), and metastasectomy has been shown to be hopeful in prolonging the survival and improving the quality of life in some of these patients. Patients with oligometastatic disease and good performance status have better results following this multimodal approach. Cytoreductive nephrectomy and adjuvant/neoadjuvant systemic therapies (immunotherapy, targeted therapy) have been investigated for treatment options of metastatic renal cancer patients. After better understanding of the genetic basis and the molecular biology of the renal cell carcinoma, targeted molecular therapies and immunotherapies have emerged as more efficient alternative therapy options with moderate adverse effects. Metastasectomy in some of these patients improves survival and quality of life, especially in those with lung and bone metastases. In this review we will summarize treatment options for metastatic renal cancer patients.
Authors and Affiliations
K. Fehmi Narter, Bora Özveren
Keywords
Related Articles
- EP ID EP379708
- DOI 10.4274/uob.962
- Views 128
- Downloads 0
Predicting Lamina Propria Invasion in Patients with Nonmuscle- invasive Bladder Cancer: Do RDW and NLR Really Work?
Objective: To determine the role of preoperative neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW) in predicting lamina propria invasion in bladder cancer. Materials and Methods: Eighty-eight pat...
The Effect of Tumor Size on Oncologic Outcomes in Pathological T2 Stage Renal Cell Carcinoma Patients
Objective: To evaluate the oncologic outcomes in T2 stage renal cell carcinoma (RCC) patients who underwent open radical nephrectomy and the effect of patient’s tumor size on the oncologic outcomes. Materials and Methods...
Active Surveillance in Prostate Cancer
With the widespread use of the prostate specific antigen and prostate biopsies there has been dramatic increase in the incidence of clinically localized prostate cancer. Although there is no consensus about the treatment...
Robotic-assisted Laparoscopic Prostatectomy: Initial Experience of 267 Cases
Objective: To present our experience of 267 consecutive patients treated with robotic-assisted laparoscopic prostatectomy (RALP) and assess the perioperative and postoperative outcomes. Materials and Methods: Materials a...
Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
Muscle invasive bladder cancer (MIBC) is an aggressive tumor with a high rate of early systemic dissemination. The main treatment for MIBC is still radical cystectomy and lymph node dissection. Survival rates for 5-year...